【Drug Name】
Generic Name: Rivaroxaban Tablets
English name: Rivaroxaban Tablets
Hanyu Pinyin: Lifashaban Pian

【Ingredients】
Main components: Rivaroxaban
Chemical name: 5-chloro-azo-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-azolidin-5-yl}methyl)-2-thiophene-carboxamide


【Properties】
This product is red film-coated tablets, white or off-white color after removing the coating.

【Indications】
For use in adult patients undergoing elective hip or knee replacement surgery to prevent venous thrombosis (VTE).
For the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) in adults; for reducing the risk of recurrence of DVT and/or PE in patients with a persistent risk of recurrence of DVT and/or PE after completion of at least 6 months of initial therapy. (See [PRECAUTIONS] for patients with hemodynamically unstable PE)
For use in adult patients with non-valvular atrial fibrillation with one or more risk factors (e.g., congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, history of stroke or transient ischemic attack) to reduce the risk of stroke and embolism in the body circulation.
Limited data are available on the relative effectiveness of rivaroxaban in reducing the risk of stroke and body circulation embolism compared to warfarin under well-controlled conditions treated with warfarin.


【Specification】
10mg/tablet